Ozempic, Wegovy, Rybelsus, Trulicity, Zepbound and Mounjaro drugs remain approved by the U.S
These symptoms may indicate dangerous drug interactions requiring immediate attention
This is especially true in people with a history of seizures or epilepsy
Tesamorelin Regulatory Status As of June 2026 , tesamorelin (brand name Egrifta) is FDA-approved for reduction of excess abdominal fat in HIV-infected adults with lipodystrophy
The authors suggest that maintaining extremely large weight losses may be harder biologically
In some instances, the formulations described herein provide a deliverable osmolarity (e.g., at a target site (e.g., perilymph) that causes minimal disturbance to the environment of the inner ear and causes minimum discomfort (e.g., vertigo and/or nausea) to a mammal upon administration